Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.
van der Pol
M A
MA
Feller
N
N
Ossenkoppele
G J
GJ
Weijers
G W D
GW
Westra
A H
AH
van Stijn
A
A
Broxterman
H J
HJ
Schuurhuis
G J
GJ
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001853:Bone Marrow / Q000473:pathology; D006801:Humans; D007951:Leukemia, Myeloid / Q000175:diagnosis* / Q000473:pathology; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000473:pathology; D011237:Predictive Value of Tests; D018709:Statistics, Nonparametric
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1